Recombinant Escherichia coli Uncharacterized protein yafS (yafS)

Shipped with Ice Packs
In Stock

Description

Overview of Uncharacterized Proteins in E. coli

Approximately 34% of E. coli proteins remain functionally uncharacterized, termed "orphans" [ ]. These proteins often participate in conserved biological processes, such as:

  • Metabolism (e.g., aromatic amino acid biosynthesis, nucleotide transport)

  • Protein synthesis (e.g., ribosome assembly, tRNA modification)

  • DNA replication and repair

  • Flagellar biogenesis and motility [ ].

Many orphans form part of multiprotein complexes or modules, as shown by proteomic interaction networks [ ].

2.1. Proteomic and Genomic Context Analysis

  • Physical interaction (PI) networks: Affinity purification coupled with mass spectrometry identifies protein complexes. Example: YafP interacts with flagellar motor components to regulate motility [ ].

  • Genomic context (GC) methods: Coevolutionary patterns predict functional linkages (e.g., operon proximity, gene fusion).

2.2. Phenotypic Screening

  • Mutant strain analysis: Deletion of orphans like yafP or ybcM impairs motility or translation fidelity [ ].

  • Chemical-genetic profiling: Assess sensitivity to antibiotics or metabolic stressors.

Hypothetical Framework for Studying YafS

While YafS is not explicitly discussed in the provided sources, the following steps could elucidate its function:

3.1. Sequence and Domain Analysis

  • Homology detection: Compare YafS against databases (e.g., COGs, Pfam) to identify conserved domains.

  • Operon context: Examine neighboring genes (e.g., yafR, yafQ) for functional clues.

3.2. Experimental Validation

ApproachApplication to YafS
Knockout strainTest growth defects under stress (e.g., heat, oxidative)
Co-purificationIdentify interacting partners via SPA-tagging [ ]
RNA-seqProfile transcriptomic changes in ΔyafS mutants

3.3. Comparative Genomics

  • Conservation analysis: Check for YafS homologs in pathogenic E. coli strains or related species.

  • Metagenomic distribution: Assess prevalence in environmental or host-associated microbiomes [ ].

Challenges in Orphan Protein Research

  • Functional redundancy: Overlapping roles with annotated proteins may obscure phenotypic effects.

  • Condition-specific activity: YafS might function only under niche conditions (e.g., biofilm formation, host infection).

Future Directions

  • CRISPR-interference screens: Systematically perturb yafS expression alongside other orphans.

  • Cryo-EM or X-ray crystallography: Resolve YafS structure to infer mechanistic roles.

Product Specs

Form
Lyophilized powder. We will preferentially ship the available format. For specific format requirements, please note them when ordering.
Lead Time
Delivery time varies based on purchasing method and location. Consult local distributors for specific delivery times. All proteins are shipped with blue ice packs by default. For dry ice shipment, contact us in advance (extra fees apply).
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Briefly centrifuge the vial before opening. Reconstitute protein in sterile deionized water to 0.1-1.0 mg/mL. Add 5-50% glycerol (final concentration) and aliquot for long-term storage at -20°C/-80°C. Default glycerol concentration is 50%.
Shelf Life
Shelf life depends on storage conditions, buffer, temperature, and protein stability. Liquid form: 6 months at -20°C/-80°C. Lyophilized form: 12 months at -20°C/-80°C.
Storage Condition
Store at -20°C/-80°C upon receipt. Aliquot for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during manufacturing. If you require a specific tag, please inform us, and we will prioritize its development.
Synonyms
yafS; b0213; JW0203; Uncharacterized protein YafS
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-240
Protein Length
full length protein
Purity
>85% (SDS-PAGE)
Species
Escherichia coli (strain K12)
Target Names
yafS
Target Protein Sequence
MKPARVPQTV VAPDCWGDLP WGKLYRKALE RQLNPWFTKM YGFHLLKIGN LSAEINCEAC AVSHQVNVSA QGMPVQVQAD PLHLPFADKS VDVCLLAHTL PWCTDPHRLL READRVLIDD GWLVISGFNP ISFMGLRKLV PVLRKTSPYN SRMFTLMRQL DWLSLLNFEV LHASRFHVLP WNKHGGKLLN AHIPALGCLQ LIVARKRTIP LTLNPMKQSK NKPRIRQAVG ATRQCRKPQA
Uniprot No.

Q&A

What defines YafS as an "uncharacterized protein" in E. coli?

YafS belongs to a class of proteins whose physiological functions remain undetermined despite genome annotation. Uncharacterized proteins like YafS are typically identified through genomic sequencing but lack experimental validation of their biological roles. Similar to the approach used for other uncharacterized proteins in E. coli, researchers can employ computational prediction tools to generate functional hypotheses before experimental validation . The classification as "uncharacterized" indicates that despite its presence in the genome, YafS has not undergone systematic functional characterization through binding assays, phenotypic studies, or structural analysis.

What bioinformatic approaches should I use for initial analysis of YafS?

Begin with sequence homology searches using BLAST against characterized proteins to identify potential functional domains. Follow with multiple sequence alignment to identify conserved residues across bacterial species. For more comprehensive analysis:

  • Use protein family databases (Pfam, InterPro) to identify conserved domains

  • Apply secondary structure prediction tools (PSIPRED, JPred)

  • Conduct genomic context analysis to identify operons or gene clusters

  • Use subcellular localization prediction (PSORTb, CELLO)

  • Employ protein-protein interaction prediction tools

This multi-faceted approach can generate testable hypotheses about YafS function, similar to methods that helped identify functions of previously uncharacterized transcription factors in E. coli .

How can genomic context inform YafS function prediction?

Analyze genes adjacent to yafS to identify potential functional relationships:

Analysis MethodImplementationExpected Output
Operon predictionDOOR, OperonDB, ProOpDBCo-transcribed gene clusters
Conserved neighborhoodSyntTax, GeCoConservation of gene order across species
Transcriptional correlationE. coli microarray databasesCo-regulation patterns
Protein-protein interactionsSTRING databasePredicted functional associations

The genomic context analysis approach has successfully revealed functions of numerous uncharacterized proteins in E. coli, providing clues about potential regulatory networks and metabolic pathways .

What expression systems are optimal for recombinant YafS production?

The optimal expression system depends on experimental goals. For initial characterization:

  • pET system with T7 promoter offers high-level expression under IPTG induction

  • pBAD system provides tunable expression with arabinose

  • pCold system may improve solubility by cold-shock induction

E. coli BL21(DE3) remains the preferred host for initial attempts, with specialized strains like Rosetta for rare codon usage or Origami for disulfide bond formation if needed. When facing solubility issues with YafS, consider trying multiple expression systems in parallel, as research shows different uncharacterized proteins respond differently to various expression conditions .

How can I improve solubility of recombinant YafS?

Solubility optimization is crucial for obtaining functional protein. Implement these strategies:

  • Lower induction temperature (16-25°C) to slow protein folding

  • Reduce inducer concentration for slower expression

  • Use solubility-enhancing fusion tags (SUMO, MBP, thioredoxin)

  • Co-express with molecular chaperones (GroEL/ES, DnaK/J)

  • Optimize media composition (additives like sorbitol, betaine)

  • Screen buffer conditions during purification

This methodical approach addresses the challenge of inclusion body formation that frequently occurs with recombinant proteins in E. coli . According to recent systematic reviews, approximately 30-40% of recombinant proteins form inclusion bodies in E. coli, requiring dedicated solubility optimization protocols .

What methods can effectively recover active YafS from inclusion bodies?

When YafS forms inclusion bodies, consider these refolding strategies:

Refolding MethodProcedureAdvantagesSuccess Indicators
DilutionSolubilize in urea/GuHCl; dilute slowly into refolding bufferSimple implementationClear solution without precipitate
DialysisGradual removal of denaturantGentle refoldingRetention of secondary structure
On-column refoldingBind denatured protein to affinity column; decrease denaturantPrevents aggregationHigh recovery from column
Pulse refoldingStepwise addition of denatured protein to refolding bufferMinimizes aggregationIncreased yield of active protein

Success rates for refolding vary significantly based on protein characteristics, but optimized protocols can achieve 15-45% recovery of active protein from inclusion bodies . Monitor refolding success using activity assays or biophysical methods like DSF .

What purification strategy is recommended for recombinant YafS?

Design a multi-step purification strategy:

  • Select appropriate affinity tag (His6, GST, MBP) based on expression results

  • Implement initial capture using affinity chromatography

  • Remove tag if it interferes with functional studies

  • Apply ion exchange chromatography as intermediate purification

  • Finalize with size exclusion chromatography for highest purity

  • Verify purity by SDS-PAGE (>95% for structural studies)

Optimize buffer conditions throughout purification to maintain protein stability. For uncharacterized proteins like YafS, testing multiple buffer systems (pH 6.0-8.0, various salt concentrations, and stabilizing additives) is critical to prevent aggregation during purification .

How can I assess proper folding and stability of purified YafS?

Apply these complementary biophysical techniques:

  • Differential Scanning Fluorimetry (DSF): Determine thermal stability and identify stabilizing buffer conditions. This requires only ~2 μg of protein per reaction and can be performed in standard qPCR instruments with SYPRO Orange dye .

  • Circular Dichroism (CD): Analyze secondary structure elements.

  • Size Exclusion Chromatography coupled with Multi-Angle Light Scattering (SEC-MALS): Determine oligomeric state and homogeneity.

  • Limited proteolysis: Identify stable domains and flexible regions.

Monitor stability in various buffers to establish optimal conditions for downstream functional assays. DSF has become particularly valuable for characterizing uncharacterized proteins, providing thermal denaturation profiles that indicate proper folding and can guide buffer optimization .

What analytical methods can help determine if YafS is a DNA-binding protein?

Several techniques can test for DNA-binding activity:

TechniquePrincipleInformation GainedSample Requirement
Electrophoretic Mobility Shift Assay (EMSA)Protein-bound DNA migrates slowerQualitative binding0.1-1 μg protein
Fluorescence AnisotropyChange in rotation of fluorescent DNABinding kinetics, Kd0.5-5 μg protein
Multiplexed ChIP-exoAntibody pulldown with exonuclease treatmentIn vivo binding sitesCells expressing tagged protein
DNA footprintingProtection of DNA from nuclease digestionBinding site sequence1-10 μg protein
Isothermal Titration Calorimetry (ITC)Heat changes upon bindingThermodynamic parameters0.5-2 mg protein

The multiplexed ChIP-exo method has been particularly successful in identifying DNA binding sites for previously uncharacterized transcription factors in E. coli, allowing researchers to identify regulatory targets with high precision .

How can I determine if YafS functions as a transcription factor?

Implement a multi-tiered approach:

  • DNA binding assessment: Use ChIP-exo to map genome-wide binding sites, which has successfully characterized 34 out of 40 candidate transcription factors in E. coli .

  • Motif analysis: Identify consensus binding sequences from ChIP data.

  • Transcriptome analysis: Compare RNA-seq data between wild-type and yafS deletion strains to identify differentially expressed genes.

  • Reporter assays: Verify direct regulation using promoter-reporter constructs.

  • Co-localization with RNA polymerase: Analyze the overlap between YafS binding sites and RNA polymerase binding, as done for other uncharacterized transcription factors where 48% (283/588) of binding sites showed overlap with RNA polymerase .

This systematic approach has proven effective in characterizing novel transcription factors in E. coli, providing insights into their regulatory networks and biological functions .

What strategies are effective for phenotypic characterization of YafS function?

Create and analyze yafS knockout strains:

  • Generate clean deletion using λ Red recombineering or CRISPR-Cas9

  • Conduct comprehensive phenotypic screening:

    • Growth rate in various media conditions

    • Stress response assays (oxidative, pH, temperature, osmotic)

    • Metabolic profiling

    • Antibiotic susceptibility

    • Biofilm formation

  • Perform complementation studies to confirm phenotype specificity

  • Use high-throughput fitness assays across hundreds of conditions

Comparative phenotypic analysis between wild-type and mutant strains has successfully identified functions for previously uncharacterized proteins in E. coli, as demonstrated in the study of YfeC, YciT, YbcM, and YgbI .

How can I identify potential interaction partners of YafS?

Apply these complementary approaches:

ApproachMethodAdvantagesLimitations
In vivoTandem Affinity Purification (TAP)Native conditionsMay miss transient interactions
In vivoBacterial Two-Hybrid (B2H)Detects direct interactionsPotential false positives
In vitroPull-down assaysControlled conditionsMay not reflect in vivo interactions
In silicoComputational predictionGenome-wide coverageRequires experimental validation
StructuralHydrogen-deuterium exchange mass spectrometryMaps interaction surfacesRequires specialized equipment

Verification of interactions through multiple methods strengthens confidence in results. For uncharacterized proteins, combining computational predictions with experimental validation has proven most effective in identifying genuine interaction partners .

What strategies can overcome challenges in structural determination of YafS?

Structural characterization requires systematic optimization:

  • Construct optimization: Create multiple constructs with varying N/C-terminal boundaries based on limited proteolysis and bioinformatic prediction.

  • Expression screening: Test constructs in parallel using small-scale expression in multiple E. coli strains.

  • Crystallization approaches:

    • High-throughput sparse matrix screening

    • Surface entropy reduction mutations

    • In situ proteolysis during crystallization

    • Co-crystallization with binding partners

  • Alternative methods: When crystallization proves challenging, consider NMR (for proteins <30 kDa) or cryo-EM (for larger assemblies).

The success of structural studies depends significantly on protein stability and homogeneity, underscoring the importance of thorough biophysical characterization before attempting structural determination .

How can computational methods complement experimental approaches for YafS structure prediction?

Integrate computational methods with experimental data:

  • Use homology modeling if templates with >30% sequence identity exist

  • Apply threading methods (I-TASSER, Phyre2) for remote homologs

  • Implement ab initio modeling for novel folds

  • Validate predictions with experimental constraints:

    • Secondary structure from CD spectroscopy

    • Domain boundaries from limited proteolysis

    • Residue proximity from crosslinking mass spectrometry

  • Refine models with molecular dynamics simulations

Computational predictions provide working models to guide experimental design and interpretation, particularly valuable for uncharacterized proteins with limited structural information .

How can I position YafS within the broader E. coli regulatory network?

Implement a systems biology approach:

  • Identify direct regulatory targets through ChIP-exo and transcriptomics

  • Map interactions with other regulatory proteins

  • Contextualize function within established regulatory circuits

  • Use network analysis to predict functional associations

  • Develop testable models of regulatory influence

This integrative approach has successfully placed previously uncharacterized transcription factors within the broader transcriptional regulatory networks of E. coli, revealing their roles in coordinating cellular responses to environmental changes .

What technologies can accelerate the functional characterization of YafS?

Leverage advanced technologies for comprehensive characterization:

TechnologyApplicationOutputResources Required
CRISPRi screeningIdentify genetic interactionsGrowth phenotypes in various conditionsGenome-wide guide RNA library
Ribosome profilingTranslation effectsTranslational efficiency changesRNA sequencing capabilities
ProteomicsGlobal protein changesDifferentially abundant proteinsMass spectrometry
MetabolomicsMetabolic impactAltered metabolite profilesLC-MS/MS or NMR
ChIP-seqGenome-wide bindingDNA binding locationsNext-generation sequencing

Integration of multiple omics approaches provides a comprehensive understanding of protein function that cannot be achieved through any single method .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.